125 related articles for article (PubMed ID: 26191187)
21. MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance.
Jegathesan Y; Stephen PP; Sati ISEE; Narayanan P; Monif M; Kamarudin MNA
Biomed Pharmacother; 2024 Mar; 172():116277. PubMed ID: 38377734
[TBL] [Abstract][Full Text] [Related]
22. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.
Bunevicius A; Deltuva VP; Tamasauskas S; Smith T; Laws ER; Bunevicius R; Iervasi G; Tamasauskas A
Oncotarget; 2017 Jan; 8(5):8648-8656. PubMed ID: 28055959
[TBL] [Abstract][Full Text] [Related]
23. Structural plasticity of the bilateral hippocampus in glioma patients.
Yuan T; Ying J; Zuo Z; Gui S; Gao Z; Li G; Zhang Y; Li C
Aging (Albany NY); 2020 Jun; 12(11):10259-10274. PubMed ID: 32507763
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.
Wager M; Guilhot J; Blanc JL; Ferrand S; Milin S; Bataille B; Lapierre F; Denis S; Chantereau T; Larsen CJ; Karayan-Tapon L
Br J Cancer; 2006 Oct; 95(8):1062-9. PubMed ID: 17047653
[TBL] [Abstract][Full Text] [Related]
25. Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer.
Deng X; Das S; Kaur H; Wilson E; Camphausen K; Shankavaram U
BMC Med Genomics; 2023 Jul; 16(1):168. PubMed ID: 37454191
[TBL] [Abstract][Full Text] [Related]
26. A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.
Bogdańska MU; Bodnar M; Piotrowska MJ; Murek M; Schucht P; Beck J; Martínez-González A; Pérez-García VM
PLoS One; 2017; 12(8):e0179999. PubMed ID: 28763450
[TBL] [Abstract][Full Text] [Related]
27. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract][Full Text] [Related]
28. Expression of microRNA-184 in glioma.
Wu XB; Yang W; Fan G; Lin WR; Liu F; Lu ZM
Oncol Lett; 2018 Jan; 15(1):727-730. PubMed ID: 29422963
[TBL] [Abstract][Full Text] [Related]
29. 14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.
Liu L; Liu Z; Wang H; Chen L; Ruan F; Zhang J; Hu Y; Luo H; Wen S
Exp Ther Med; 2018 Mar; 15(3):2381-2387. PubMed ID: 29467845
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and survival analyses of 333 adult glioma patients from Eastern Algeria (2008-2016).
Touati S; Djekkoun R; El-Okki ME; Satta D
Afr Health Sci; 2020 Sep; 20(3):1250-1258. PubMed ID: 33402972
[TBL] [Abstract][Full Text] [Related]
31. Expression of TXLNA in brain gliomas and its clinical significance: a bioinformatics analysis.
Hu B; Chen D; Li Y; Yu S; Kuang L; Ma X; Yang Q; He K; Zhao Y; Wang G; Guo M
Chin Neurosurg J; 2023 Sep; 9(1):27. PubMed ID: 37752559
[TBL] [Abstract][Full Text] [Related]
32. Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma.
Shi H; Luo K; Huang W
Onco Targets Ther; 2020; 13():8723-8734. PubMed ID: 32943880
[TBL] [Abstract][Full Text] [Related]
33. Actin Alpha 2, Smooth Muscle (ACTA2) Is Involved in the Migratory Potential of Malignant Gliomas, and Its Increased Expression at Recurrence Is a Significant Adverse Prognostic Factor.
Hoshimaru T; Nonoguchi N; Kosaka T; Furuse M; Kawabata S; Yagi R; Kurisu Y; Kashiwagi H; Kameda M; Takami T; Kataoka-Sasaki Y; Sasaki M; Honmou O; Hiramatsu R; Wanibuchi M
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891844
[TBL] [Abstract][Full Text] [Related]
34. Chronic stress as an emerging risk factor for the development and progression of glioma.
Yi L; Lin X; She X; Gao W; Wu M
Chin Med J (Engl); 2024 Feb; 137(4):394-407. PubMed ID: 38238191
[TBL] [Abstract][Full Text] [Related]
35. Glioma Single-Cell Biomechanical Analysis by Cyclic Conical Constricted Microfluidics.
Geng X; Zhou ZA; Mi Y; Wang C; Wang M; Guo C; Qu C; Feng S; Kim I; Yu M; Ji H; Ren X
Anal Chem; 2023 Oct; 95(42):15585-15594. PubMed ID: 37843131
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis.
Hasani F; Masrour M; Jazi K; Ahmadi P; Hosseini SS; Lu VM; Alborzi A
Front Neurol; 2024; 15():1357321. PubMed ID: 38487328
[TBL] [Abstract][Full Text] [Related]
37. Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review.
Dabbagh Ohadi MA; Aleyasin MS; Samiee R; Bordbar S; Maroufi SF; Bayan N; Hanaei S; Smith TR
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509289
[TBL] [Abstract][Full Text] [Related]
38. The role of microRNA in the pathogenesis of glial brain tumors.
Beylerli O; Gareev I; Sufianov A; Ilyasova T; Zhang F
Noncoding RNA Res; 2022 Jun; 7(2):71-76. PubMed ID: 35330864
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis.
Gasparello J; Papi C; Zurlo M; Gambari L; Rozzi A; Manicardi A; Corradini R; Gambari R; Finotti A
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209084
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a prognostic-related microRNAs risk model for glioma by bioinformatics analysis.
Wang Y; Zhang C; Lu W; Chen R; Yu M
Ann Transl Med; 2021 Jun; 9(12):1022. PubMed ID: 34277822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
